A Prospective Randomized Clinical Trial of Vincristine versus Human Intravenous Immunoglobulin for Acute Adjunctive Management of Presumptive Primary Immune-Mediated Thrombocytopenia in Dogs
Open Access
- 25 March 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 27 (3) , 536-541
Abstract
Background Dogs with immune‐mediated thrombocytopenia (ITP) are at risk of hemorrhage when platelet count is P = .51). Median hospitalization time for all dogs that survived to discharge was 4 days and not different between groups (P = .29). Seven of 10 dogs in the hIVIG group and 10 of 10 in the VINC group survived to discharge. Survival analysis did not identify any significant difference between the groups at discharge, 6 months, and 1 year after entry into the study. No adverse effects were reported in either group. Conclusions and Clinical Importance Vincristine should be the first‐line adjunctive treatment for the acute management of canine ITP because of lower cost and ease of administration compared with human intravenous immunoglobulin (hIVIG).Keywords
This publication has 13 references indexed in Scilit:
- Idiopathic Immune-Mediated Thrombocytopenia and Recent Vaccination in DogsJournal of Veterinary Internal Medicine, 2011
- A review of current indications, adverse effects, and administration recommendations for intravenous immunoglobulinJournal of Veterinary Emergency and Critical Care, 2011
- Treatment and predictors of outcome in dogs with immune-mediated thrombocytopeniaJournal of the American Veterinary Medical Association, 2011
- Prothrombotic and Inflammatory Effects of Intravenous Administration of Human Immunoglobulin G in DogsJournal of Veterinary Internal Medicine, 2009
- A Prospective, Randomized, Double-Blinded, Placebo-Controlled Study of Human Intravenous Immunoglobulin for the Acute Management of Presumptive Primary Immune-Mediated Thrombocytopenia in DogsJournal of Veterinary Internal Medicine, 2009
- Primary Immune-mediated Thrombocytopenia in 30 Dogs (1997–2003)Journal of the American Animal Hospital Association, 2008
- Comparison of platelet count recovery with use of vincristine and prednisone or prednisone alone for treatment for severe immune-mediated thrombocytopenia in dogsJournal of the American Veterinary Medical Association, 2002
- Vincristine Impairs Platelet Aggregation in Dogs with LymphomaJournal of Veterinary Internal Medicine, 2000
- Effects of human intravenous immunoglobulin on canine monocytes and lymphocytesAmerican Journal of Veterinary Research, 1998
- Canine Idiopathic Thrombocytopenic PurpuraJournal of Veterinary Internal Medicine, 1996